{
    "clinical_study": {
        "@rank": "114266", 
        "arm_group": {
            "arm_group_label": "MoodGYM", 
            "arm_group_type": "Experimental", 
            "description": "This study is a single-arm intervnetion. All subjects will be assigned to receive six weeks of online CBT through MoodGYM."
        }, 
        "brief_summary": {
            "textblock": "This study aims to evaluate efficacy and acceptability of the Chinese language version of\n      MoodGYM as a therapeutic intervention in treating symptoms of depression in community\n      dwelling Chinese Americans in the Boston area.\n\n      Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in\n      depressive symptoms after completion of the 5 modules.\n\n      Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved\n      dysfunctional thinking.\n\n      Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally\n      acceptable."
        }, 
        "brief_title": "Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans", 
        "condition": "Major Depressive Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Depressive Disorder", 
                "Depression", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Resident of the US, but self-identified as Chinese origin\n\n          -  At least 18 years of age\n\n          -  Proficiency in Chinese, including the ability to read Chinese\n\n          -  Access to computer and internet\n\n          -  Scores > 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)\n\n        Exclusion Criteria:\n\n          -  Current ongoing psychiatric or psychological treatment\n\n          -  Using illicit drugs or consumption > 3 standard drinks in a day\n\n          -  Currently experiencing a psychotic illness\n\n          -  Past or current history of schizophrenia or bipolar disorder\n\n          -  ECT during the last year\n\n          -  Current active suicidal or self-injurious potential necessitating immediate\n             face-to-face treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01851967", 
            "org_study_id": "2012-P-002340"
        }, 
        "intervention": {
            "arm_group_label": "MoodGYM", 
            "description": "MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.", 
            "intervention_name": "MoodGYM", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Major depressive disorder", 
            "Cognitive behavioral therapy", 
            "Computerized CBT", 
            "Online CBT"
        ], 
        "lastchanged_date": "May 13, 2013", 
        "link": {
            "description": "MoodGYM (English version)", 
            "url": "https://moodgym.anu.edu.au/welcome/new/splash"
        }, 
        "location": {
            "contact": {
                "email": "apisoni@partners.org", 
                "last_name": "Angela Pisoni, BA", 
                "phone": "617-726-0517"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "Massachusetts General Hospital Depression Clinical and Research Program"
            }, 
            "investigator": {
                "last_name": "Albert Yeung, MD, ScD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans", 
        "overall_contact": {
            "email": "ayeung@partners.org", 
            "last_name": "Albert Yeung, MD, ScD", 
            "phone": "617-724-5138"
        }, 
        "overall_contact_backup": {
            "email": "ainamori@partners.org", 
            "last_name": "Aya Inamori, BA", 
            "phone": "617-724-0586"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.", 
            "measure": "Change in Center for Epidemiologic Studies Depression Scale (CES-D)", 
            "safety_issue": "No", 
            "time_frame": "Weeks 0, 6 (pre/post)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01851967"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Albert Yeung", 
            "investigator_title": "Principle Investigator / Psychiatrist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}